Prognostic Value of Pan-immune-inflammation Value in Colorectal Cancer Patients: A Systematic Review and Meta-analysis

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Jan 9

PMID 36620576

Authors

Xiao-Chuan Yang

Hui Liu

Ding-Cheng Liu

Chao Tong

Xian-Wen Liang

Ri-Hui Chen

Affiliations

Soon will be listed here.

Abstract

Background: The pan-immune-inflammation value (PIV) has been reported as a novel prognostic biomarker in multiple malignancies. The aim of this study is to investigate the prognostic value of the PIV in patients with colorectal cancer.

Methods: We comprehensively searched electronic databases including PubMed, Embase and Web of Science up to August 2022. The endpoints were survival outcomes. Hazard ratios (HRs) with 95% confidence intervals (CIs) for survival data were collected for analysis.

Results: Six studies including 1879 participants were included. A significant heterogeneity in the PIV cut-off value among studies was observed. The combined results indicated that patients in the high baseline PIV group had a worse overall survival (HR=2.09; 95%CI: 1.67-2.61; P<0.0001; I 7%) and progression-free survival (HR=1.82; 95%CI: 1.49-2.22; P<0.0001; I 15%). In addition, early PIV increase after treatment initiation was significantly associated with decreased overall survival (HR=1.79; 95%CI: 1.13-2.93; P=0.01; I 26%), and a trend toward poor progression-free survival (HR=2.00; 95%CI: 0.90-4.41; P=0.09; I 70%).

Conclusion: Based on existing evidence, the PIV could act as a valuable prognostic index in patients with colorectal cancer. However, the heterogeneity in the PIV cut-off value among studies should be considered when interpreting these findings.

Citing Articles

Pan‑immune‑inflammatory values predict survival in patients after radical surgery for non‑metastatic colorectal cancer: A retrospective study.

Li K, Zeng X, Zhang Z, Wang K, Pan Y, Wu Z Oncol Lett. 2025; 29(4):197.

PMID: 40046636 PMC: 11880885. DOI: 10.3892/ol.2025.14943.

PAN-Immune inflammation value: a new biomarker for diagnosing appendicitis in children??.

Coskun N, Metin M, Dogan G, Ipek H, Demir E, Afsarlar C BMC Pediatr. 2025; 25(1):165.

PMID: 40038639 PMC: 11877757. DOI: 10.1186/s12887-025-05544-5.

Are the systemic immune-inflammation index and panimmune-inflammation value predictive indicators for the decision of operative treatment in adhesive small bowel obstruction?.

Ucaner B, Cimen S, Birgun M, Kamburoglu A, Buldanli M, Kaymak S Ulus Travma Acil Cerrahi Derg. 2025; 31(2):148-154.

PMID: 39963915 PMC: 11843422. DOI: 10.14744/tjtes.2025.59933.

Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer.

Li B, Che L, Li H, Min F, Ai B, Wu L Front Immunol. 2025; 16:1531639.

PMID: 39944700 PMC: 11813937. DOI: 10.3389/fimmu.2025.1531639.

Comprehensive analysis of Pan-Immune Inflammation and all-cause mortality in rheumatoid arthritis: a database-driven approach, 1999-2018.

Mardan M, Zheng H, Xu Q, Song S, Lu Z, Deng H Front Immunol. 2025; 16:1549955.

PMID: 39935476 PMC: 11811095. DOI: 10.3389/fimmu.2025.1549955.

References

Ceze N, Thibault G, Goujon G, Viguier J, Watier H, Dorval E . Pre-treatment lymphopenia as a prognostic biomarker in colorectal cancer patients receiving chemotherapy. Cancer Chemother Pharmacol. 2011; 68(5):1305-13. DOI: 10.1007/s00280-011-1610-3. View

Gneo L, Rizkalla N, Hejmadi R, Mussai F, De Santo C, Middleton G . TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer. Cancer Immunol Immunother. 2021; 71(7):1583-1596. PMC: 9188538. DOI: 10.1007/s00262-021-03081-5. View

Fornarini G, Rebuzzi S, Banna G, Calabro F, Scandurra G, De Giorgi U . Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort. ESMO Open. 2021; 6(3):100118. PMC: 8134706. DOI: 10.1016/j.esmoop.2021.100118. View

Fuca G, Beninato T, Bini M, Mazzeo L, Di Guardo L, Cimminiello C . The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy. Target Oncol. 2021; 16(4):529-536. DOI: 10.1007/s11523-021-00819-0. View

Lin Y, Liu Z, Qiu Y, Zhang J, Wu H, Liang R . Clinical significance of plasma D-dimer and fibrinogen in digestive cancer: A systematic review and meta-analysis. Eur J Surg Oncol. 2018; 44(10):1494-1503. DOI: 10.1016/j.ejso.2018.07.052. View

Olsson A, Cedervall J . The pro-inflammatory role of platelets in cancer. Platelets. 2018; 29(6):569-573. DOI: 10.1080/09537104.2018.1453059. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Xia J, Chen Y, Wen S, Du X, Shen B . [Peripheral Blood Inflammation Indicators as Predictive Indicators in  Immunotherapy of Advanced Non-small Cell Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2021; 24(9):632-645. PMC: 8503984. DOI: 10.3779/j.issn.1009-3419.2021.103.10. View

Guven D, Sahin T, Erul E, Kilickap S, Gambichler T, Aksoy S . The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis. Cancers (Basel). 2022; 14(11). PMC: 9179577. DOI: 10.3390/cancers14112675. View

10.

Xu B, Xu Y, Lu J, Wu Y, Wang J, Lin J . Prognostic significance of combined Lymphocyte-monocyte Ratio and Tumor-associated Macrophages in Gastric Cancer Patients after Radical Resection. J Cancer. 2020; 11(17):5078-5087. PMC: 7378932. DOI: 10.7150/jca.44440. View

11.

Watanabe K, Noma D, Masuda H, Masuda M . Preoperative inflammation-based scores predict early recurrence after lung cancer resection. J Thorac Dis. 2021; 13(5):2812-2823. PMC: 8182501. DOI: 10.21037/jtd-20-3458. View

12.

Ren H, Bosch F, Pretzsch E, Jacob S, Westphalen C, Holch J . Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer: A Retrospective Study in 1780 Patients. Ann Surg. 2022; 276(5):897-904. DOI: 10.1097/SLA.0000000000005644. View

13.

Wan S, Lai Y, Myers R, Li B, Hyslop T, London J . Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients. J Gastrointest Cancer. 2013; 44(3):293-304. PMC: 3748145. DOI: 10.1007/s12029-013-9491-9. View

14.

Zeng R, Liu F, Fang C, Yang J, Luo L, Yue P . PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients. Front Immunol. 2021; 12:724443. PMC: 8586214. DOI: 10.3389/fimmu.2021.724443. View

15.

Zhang X, Cui M, Fu S, Li L, Liu Y, Liu Z . Platelet distribution width correlates with prognosis of gastric cancer. Oncotarget. 2017; 8(12):20213-20219. PMC: 5386756. DOI: 10.18632/oncotarget.15561. View

16.

Sato S, Shimizu T, Ishizuka M, Suda K, Shibuya N, Hachiya H . The preoperative pan-immune-inflammation value is a novel prognostic predictor for with stage I-III colorectal cancer patients undergoing surgery. Surg Today. 2022; 52(8):1160-1169. DOI: 10.1007/s00595-021-02448-6. View

17.

Shibutani M, Maeda K, Nagahara H, Fukuoka T, Nakao S, Matsutani S . The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study. BMC Cancer. 2017; 17(1):404. PMC: 5460583. DOI: 10.1186/s12885-017-3395-1. View

18.

Corti F, Lonardi S, Intini R, Salati M, Fenocchio E, Belli C . The Pan-Immune-Inflammation Value in microsatellite instability-high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. Eur J Cancer. 2021; 150:155-167. DOI: 10.1016/j.ejca.2021.03.043. View

19.

Efil S, Guner G, Guven D, Celikten B, Celebiyev E, Taban H . Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer. Clin Res Hepatol Gastroenterol. 2023; 47(7):102171. DOI: 10.1016/j.clinre.2023.102171. View

20.

Li Q, Lu Z, Yang L, Lu M, Zhang X, Li J . Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 2014; 15(2):945-50. DOI: 10.7314/apjcp.2014.15.2.945. View